Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · Real-Time Price · USD
16.91
-0.07 (-0.41%)
At close: Oct 5, 2026, 4:00 PM EDT
17.07
+0.16 (0.95%)
After-hours: Oct 5, 2026, 4:55 PM EDT
Greenwich LifeSciences Market Cap
Greenwich LifeSciences has a market cap or net worth of $248.21 million as of October 5, 2026. Its market cap has increased by 66.91% in one year.
Market Cap
248.21M
Enterprise Value
239.33M
1-Year Change
66.91%
Ranking
Category
Stock Price
$16.91
ChartMarket Cap Chart
Since the IPO on September 25, 2020, Greenwich LifeSciences's market cap has increased from $68.69M to $248.21M, an increase of 261.36%. That is a compound annual growth rate of 23.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 5, 2026 | 248.21M | -14.73% |
| Dec 31, 2025 | 291.08M | 97.19% |
| Dec 31, 2024 | 147.61M | 9.21% |
| Dec 29, 2023 | 135.16M | -30.79% |
| Dec 30, 2022 | 195.29M | -38.84% |
| Dec 31, 2021 | 319.29M | -31.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vicore Pharma Holding AB | 261.45M |
| Pyxis Oncology | 255.64M |
| Sutro Biopharma | 254.52M |
| InflaRx | 253.47M |
| Evommune | 251.14M |
| Camp4 Therapeutics | 251.01M |
| Palisade Bio | 250.95M |
| Nautilus Biotechnology | 249.42M |